Clinical Trials Logo

Clinical Trial Summary

The study was established to collect data and reference measurements in order to establish calibration models for the Prototype 0.3


Clinical Trial Description

Subjects are recruited at two different sites.

Site 1: In group 1 subjects will on their regular stay in the clinic perform four measurement sessions a day. A measurement session consist of a reference capillary blood sample and two measures on the IMD.

Site 2: The study in group 2 consists of 26 home-based measurements and two in-clinic days. During the home measurements, 6 measurement sessions will be performed by the subjects a day. A measurement session consists of two reference BGMs, two reference CGMs and two measurements on the device. On in-clinic visits, subjects will be administered high glucose breakfast and the following 6-7 hours, measurement sessions are performed every 15 minutes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03781232
Study type Interventional
Source RSP Systems A/S
Contact
Status Completed
Phase N/A
Start date November 22, 2018
Completion date August 5, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05563090 - Investigating the Syndrome Differentiation of Diabetic and Pre-diabetic Using Digitalized TCM Diagnostic Tools
Recruiting NCT05333159 - The Efficacy of SGLT-2 Inhibitor in Patients With CAD and DM Undergoing PCI.
Active, not recruiting NCT03119584 - Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation Phase 4
Completed NCT04409171 - Glucose Metabolism After Partial Pancreatectomy
Recruiting NCT06060392 - Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus N/A
Completed NCT05144971 - StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation
Completed NCT03914183 - Can mCPN Intervention Improve Injection Site Rotation N/A
Not yet recruiting NCT06150508 - Randomized Controlled Trial of the Smart O2O Model Development for Chronic Diseases Management Through Digital Health N/A
Completed NCT01252810 - Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure Phase 2
Active, not recruiting NCT04171557 - Bicycling and Mortality Among Individuals With diabetesNutrition (EPIC)
Active, not recruiting NCT03155594 - CGM to Aid Transition From Inpatient to Outpatient N/A
Completed NCT04864327 - Smoking Intervention Among Patients With Diabetes N/A
Completed NCT04407182 - Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 Phase 2
Completed NCT05752591 - Hypothalamic-pituitary Dysfunction in Diabetes
Completed NCT03159546 - FreeStyle Libre Flash Glucose Monitoring System Accuracy N/A
Completed NCT03953092 - A Randomized, Double-blind, Placebo-controlled, Sequential Single and Multiple Ascending Doses of YG1699 Phase 1
Not yet recruiting NCT06262854 - Efficacy and Safety of Stimulan® for the Treatment of Diabetic Foot Osteomyelitis. The BIG D-FOOT Study N/A
Completed NCT03934281 - Study of the Value of Using a Honey Dressing Compared to the Use of a Standard Dressing on the Toe Amputation Wound in the Diabetic Patient N/A
Not yet recruiting NCT03341026 - Metronom Continuous Glucose Monitoring System N/A
Recruiting NCT03965975 - Clinical Validation Through Analytical Study With Urine Samples to Compare the Effectiveness and Security of an Intelligent Device N/A